Trial intelligence / Profile preview

Aripiprazole in Children and Adolescents With Autistic Disorder

NCT00198055Phase 2Completed

Sponsor
Indiana University School of Medicine
Start
Jan 2005
Primary completion
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of aripiprazole in Autism Spectrum Disorder (ASD), Asperger syndrome, pervasive developmental disorder (PDD), sponsored by Indiana University School of Medicine. Started Jan 2005; status: completed.

02

Drugs

aripiprazole
03

Conditions

Autism Spectrum Disorder (ASD)Asperger syndromepervasive developmental disorder (PDD)

Beyond the preview

Go deeper on NCT00198055.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00198055.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call